Bianco, M.; D’Oria, F.; Ghezzi, G.; Ibba, L.; Di Giulio, S.; Valenti, M.; Costanzo, A.; Narcisi, A.; Gargiulo, L.
Real-Life Effectiveness and Safety of Bimekizumab in Plaque Psoriasis Involving Difficult-to-Treat Areas: A 52-Week, Retrospective Real-World, Single-Center Study. J. Clin. Med. 2025, 14, 7412.
https://doi.org/10.3390/jcm14207412
AMA Style
Bianco M, D’Oria F, Ghezzi G, Ibba L, Di Giulio S, Valenti M, Costanzo A, Narcisi A, Gargiulo L.
Real-Life Effectiveness and Safety of Bimekizumab in Plaque Psoriasis Involving Difficult-to-Treat Areas: A 52-Week, Retrospective Real-World, Single-Center Study. Journal of Clinical Medicine. 2025; 14(20):7412.
https://doi.org/10.3390/jcm14207412
Chicago/Turabian Style
Bianco, Matteo, Francesco D’Oria, Gioele Ghezzi, Luciano Ibba, Sara Di Giulio, Mario Valenti, Antonio Costanzo, Alessandra Narcisi, and Luigi Gargiulo.
2025. "Real-Life Effectiveness and Safety of Bimekizumab in Plaque Psoriasis Involving Difficult-to-Treat Areas: A 52-Week, Retrospective Real-World, Single-Center Study" Journal of Clinical Medicine 14, no. 20: 7412.
https://doi.org/10.3390/jcm14207412
APA Style
Bianco, M., D’Oria, F., Ghezzi, G., Ibba, L., Di Giulio, S., Valenti, M., Costanzo, A., Narcisi, A., & Gargiulo, L.
(2025). Real-Life Effectiveness and Safety of Bimekizumab in Plaque Psoriasis Involving Difficult-to-Treat Areas: A 52-Week, Retrospective Real-World, Single-Center Study. Journal of Clinical Medicine, 14(20), 7412.
https://doi.org/10.3390/jcm14207412
